What are GLP-1 research peptides?

GLP-1 research peptides are laboratory compounds based on glucagon-like peptide-1, an incretin hormone. In research they are used to study class B G-protein-coupled receptor signaling, cAMP/PKA pathways, and glucose-dependent insulin secretion in preclinical and in-vitro models. They are for laboratory research use only — not for human or veterinary use, and not evaluated by the FDA.

What is the difference between single, dual, and triple agonist research peptides?

Single agonists engage one receptor (e.g., GLP-1R). Dual agonists such as the tirzepatide class (NL-2) engage GLP-1R and GIPR. Triple agonists such as retatrutide (NL-3 RT) add glucagon-receptor activity. Research models examine whether engaging multiple receptors produces additive metabolic effects. See our triple-agonist mechanism and NL-2 vs Retatrutide guides.

How do amylin analogs differ from GLP-1 peptides in research?

Amylin analogs like cagrilintide act through calcitonin-receptor/RAMP complexes rather than the incretin GLP-1/GIP receptors, representing a distinct satiety-signaling pathway. Research frequently examines the two pathways together; our amylin pathway mechanism guide and Cagrilintide vs GLP-1 contrast cover this.

Are MOTS-c and NAD+ considered metabolic peptides?

MOTS-c is a mitochondrial-derived peptide studied for AMPK activation and metabolic-stress signaling, so it fits the metabolic class directly. NAD+ is a redox coenzyme rather than a signaling peptide, but it is studied in cellular-energy and sirtuin research, which is why it appears in this metabolic hub.

Are NeuroLabs metabolic peptides tested for purity?

Yes. Every metabolic research compound is ≥99% purity and third-party COA-tested, with certificates available for verification. All products are supplied strictly for laboratory research use only and ship same-day within the USA.

GLP-1 Research Peptides: Metabolic & Incretin Hub

GLP-1 research peptides sit at the center of one of the most active areas in preclinical metabolic science. This hub organizes the incretin, glucagon, amylin, and cellular-energy compounds that laboratories use to interrogate energy homeostasis, nutrient signaling, adipose biology, and mitochondrial function in vitro and in animal models. Whether a research program is mapping receptor pharmacology or comparing single-, dual-, and triple-agonist candidates, this page connects the mechanism explainers, individual compound guides, and side-by-side research comparisons across the NeuroLabs metabolic catalog.

Research Use Only. All compounds referenced here are supplied strictly for laboratory, in-vitro, and preclinical research use only. They are not for human or veterinary use, are not evaluated by the FDA, and are not intended to diagnose, treat, cure, or prevent any disease. Nothing on this page is medical, therapeutic, or dosing guidance. All references describe published mechanisms and findings from research models.

What "metabolic and GLP research peptides" means in the lab

The metabolic peptide class encompasses signaling molecules that act on the pathways governing glucose handling, satiety signaling, lipolysis, and cellular energy production. Incretins — the gut-derived hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) — are the anchor of this group. In research settings they are studied for their action at class B G-protein-coupled receptors, their downstream cyclic AMP and protein kinase A signaling, and their effects on pancreatic beta-cell models and central appetite circuits.

Around this incretin core sits a widening family: glucagon-receptor agonists studied for energy expenditure in models, amylin analogs examined for their satiety-signaling role, growth-hormone-fragment peptides investigated in adipose and lipolysis research, and mitochondrial and redox compounds used to probe cellular bioenergetics. Together they let research teams dissect metabolic signaling from the receptor down to the mitochondrion.

Incretin signaling: the GLP-1, GIP, and glucagon axis

GLP-1 remains the most extensively characterized incretin in the literature. Our GLP-1 in Research: Incretin Peptide Overview introduces the peptide's structure and the receptor biology behind it, while Incretin Receptor Signaling: Mechanism Guide details how GLP-1R and GIPR couple to Gαs, elevate intracellular cAMP, and modulate glucose-dependent insulin secretion in beta-cell research models.

Much of the current interest lies in multi-receptor candidates. Dual GLP-1/GIP agonists (the tirzepatide class) and triple GLP-1/GIP/glucagon agonists are studied for the hypothesis that simultaneous receptor engagement produces additive or synergistic metabolic effects in preclinical models. The GLP-1/GIP/Glucagon Triple Agonist Mechanism explainer walks through how a single molecule can activate three distinct receptors and why glucagon-receptor activity is hypothesized to add an energy-expenditure dimension in animal studies. For the class-level framing, Triple vs Dual Agonist: Incretin Class Research contrasts the two design philosophies.

Featured incretin research compounds

Retatrutide (NL-3 RT) — a triple-agonist research peptide. See the Retatrutide (NL-3 RT) Research Guide and, for sourcing, Where to Buy Retatrutide Research Peptide (USA). Available as NL-3 RT (Retatrutide).
NL-2 (TZ) — a tirzepatide-class dual-agonist research peptide covered in the NL-2 TZ Research Guide, compared against the triple agonist in NL-2 vs Retatrutide: Incretin Research Compared. Available as NL-2 TZ.

Amylin signaling: a complementary satiety pathway

Amylin (islet amyloid polypeptide) is co-secreted with insulin and acts through calcitonin-receptor complexes with receptor-activity-modifying proteins (RAMPs). In research it is studied as a satiety-signaling pathway distinct from — but potentially complementary to — the incretin axis. Our Amylin Signaling Pathway in Metabolic Research guide maps this receptor biology, and the Cagrilintide Research Guide: Amylin Analog covers the long-acting amylin analog most used in current studies. Because amylin and GLP-1 pathways are frequently examined together, see Cagrilintide vs GLP-1 Agonists: Research Contrast and the direct Retatrutide vs Cagrilintide: Metabolic Research comparison. Cagrilintide is available as Cagrilintide 5mg; sourcing is covered in Where to Buy Cagrilintide Research Peptide (USA).

Adipose and lipolysis research peptides

A separate branch of metabolic research focuses directly on adipose tissue. AOD-9604, a modified fragment of human growth hormone (the 176-191 region), is studied for its hypothesized effect on lipolytic pathways without the broader growth-hormone signaling of the full molecule. The AOD-9604 Research Guide: hGH Fragment 176-191 introduces the compound, AOD-9604 & Lipolysis: Mechanism Explainer details the proposed beta-3 adrenergic and lipase-related mechanisms examined in vitro, and AOD-9604 vs Tesamorelin: Fat-Research Compared contrasts it with a growth-hormone-releasing approach. AOD-9604 is available as AOD-9604 5mg; see also Where to Buy AOD-9604 Research Peptide (USA).

Tesamorelin, a growth-hormone-releasing hormone analog, is studied specifically in visceral-adipose research models — the focus of Tesamorelin & Visceral Adipose Research Models. It is available as Tesamorelin 10mg.

Cellular energy: mitochondrial and redox research peptides

Metabolism ultimately resolves to the mitochondrion, and several compounds in this hub probe cellular bioenergetics directly. MOTS-c is a mitochondrial-derived peptide studied for its activation of AMP-activated protein kinase (AMPK) and its role in metabolic-stress signaling — see the MOTS-c Research Guide: Mitochondrial Peptide and the mechanism-focused MOTS-c & AMPK: Mitochondrial Mechanism Guide. It is available as MOTS-c 40mg.

NAD+ (nicotinamide adenine dinucleotide) is a central coenzyme in redox reactions and a substrate for sirtuins and other enzymes; the NAD+ Research Guide: Cellular Coenzyme Study and NAD+ & Sirtuins: Cellular Energy Mechanism cover its research role. NAD+ is available as NAD+ 500mg. Glutathione, the master antioxidant tripeptide, is studied for redox balance — see the Glutathione Research Guide: Antioxidant Tripeptide and Glutathione & Redox Balance: Mechanism Guide. Available as Glutathione. Because these overlap conceptually, research teams often compare them: MOTS-c vs NAD+: Metabolic Research Compared and Glutathione vs NAD+: Antioxidant Research.

Comparing metabolic research peptides

Choosing the right reference compound for a study design often comes down to mechanism. These comparison guides sit alongside the individual profiles to help research teams frame their models:

Metabolic Peptides Compared: NL Series Overview — a top-level map of the NL-series incretin candidates.
Retatrutide vs Cagrilintide — triple agonist vs amylin analog.
NL-2 vs Retatrutide — dual vs triple incretin agonism.
Cagrilintide vs GLP-1 Agonists — amylin vs incretin pathways.
AOD-9604 vs Tesamorelin — fragment vs GHRH-analog adipose research.

Laboratory handling of metabolic research preparations

Most of these compounds are supplied as lyophilized powder for laboratory reconstitution. As a general research-handling note, lyophilized peptides are typically stored desiccated at -20°C and reconstituted with bacteriostatic or sterile water for the intended in-vitro assay, with reconstituted solutions kept refrigerated and protected from repeated freeze-thaw. Every NeuroLabs metabolic compound is ≥99% purity and third-party COA-tested, with certificates available for verification. This is laboratory preparation guidance only and is not a use protocol.

Explore the NeuroLabs metabolic research library

Start with a mechanism hub — GLP-1 overview, amylin signaling, MOTS-c & AMPK, or NAD+ & sirtuins — then move to the individual compound guides and comparisons linked throughout this page. For ordering or COA requests, contact neurolabsresearch3@gmail.com. All products ship same-day within the USA for laboratory research use only.